All In Biotech

Drug Trial Radar · NCT00269438

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium Dosed Twice Daily in Achieving Clinical Improvement in Subjects With Mildly to Moderately Active Ulcerative Colitis After 8 Weeks of Therapy

Last checked: Nov 20, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 225 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

225

Actual

Start

Dec 2005

Primary completion

Mar 2007

Study completion Jun 2007

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Dec 23, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with mildly to moderately active ulcerative colitis after 8 weeks of therapy.

Conditions

  • Ulcerative Colitis

Interventions

  • 5 ASA, enemas, suppositories, corticosteroidsDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects that achieve clinical improvement and improvement in the rectal bleeding subscale of the MMDAI at the end of eight weeks of therapy, where clinical improvement is defined as a >3 point improvement from baseline in the MMDAI.

Locations

66 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Gastroenterology Associates

    Birmingham, Alabama

  • Spring Memorial Hospital

    Mobile, Alabama

  • Little Rock Diagnostic Clinic

    Little Rock, Arkansas

  • Advanced Clinical Research Institute

    Anaheim, California

  • Lovelace Scientific Resources

    Beverly Hills, California

  • Digestive Liver Disease Specialists, Medical Group

    Garden Grove, California

  • Therapeutic Research Institute of Orange County

    Laguna Hills, California

  • Long Beach VA Medical Center

    Long Beach, California

  • Facey Medical Group

    Mission Hills, California

  • Community Clinical Trials

    Orange, California

  • Rider Research Group

    San Francisco, California

  • John Jolley, M.D.

    San Rafael, California

  • Lovelace Scientific Resources

    Santa Ana, California

  • Santa Barbara Clinical Research

    Santa Barbara, California

  • Connecticut Gastroenterology Institute

    Bristol, Connecticut

  • Stamford Therapeutic Consortium

    Stamford, Connecticut

  • Medical Research Unlimited

    Hialeah, Florida

  • Mark Lamet, M.D.

    Hollywood, Florida

  • Southern Clinical Research Consultants

    Hollywood, Florida

  • United Medical Research

    New Smyrna Beach, Florida

  • Venture Research Institute, LLC

    North Miami Beach, Florida

  • Advanced Gastroenterology Associates

    Palm Harbor, Florida

  • Lovelace Scientific Resources

    Sarasota, Florida

  • Advent Clinical Research

    Sarasota, Florida

  • Clinical Research of Tampa Bay, Inc.

    Spring Hill, Florida

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida

  • Gary Richter, M.D.

    Atlanta, Georgia

  • The Atlanta Center for Gastroenterology

    Decatur, Georgia

  • Gastroenterology Associates of Central Georgia

    Macon, Georgia

  • Northwest Gastroenterologists S.C.

    Arlington Heights, Illinois

  • University Digestive Health Center

    Oak Forest, Illinois

  • Covenent Clinic

    Waterloo, Iowa

  • Digestive Health Center

    Topeka, Kansas

  • University of Louisville

    Louisville, Kentucky

  • Digestive Health Center of Louisiana

    Baton Rouge, Louisiana

  • Woodholme Gastroenterology Associates, PA

    Baltimore, Maryland

  • Sinai Medical Office Building

    Baltimore, Maryland

  • Mid Atlantic Medical Research Centers

    Hollywood, Maryland

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan

  • Site not named

    Kansas City, Missouri

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.